Splenomegaly due to the use of granulocyte-colony stimulating factor

Turkish Journal of Haematology

Volumn 21, Issue 2, 2004, Pages 93-96

  Barlak, Ahmet ^a   Kadiköylü, Gürhan ^a   Bolaman, A Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Colony stimulating factor; Splenomegaly

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; DRUG WITHDRAWAL; ECHOGRAPHY; FATIGUE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LEUKEMIA REMISSION; LYMPHOCYTE; NEUTROPHIL; PETECHIA; PHYSICAL EXAMINATION; PURPURA; RASH; SPLENOMEGALY; STEM CELL MOBILIZATION;

EID: 3142741724     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. James D. Griffin. Hematopoietic growth factors. In: Hellman Samuel Jr, Rosenberg SA (eds). De Vira VT Principles and Practice of Oncology. 6th ed. Philadelphia: USA, 2001:2798-813.
2. Cesaro S, Marson P, Gazzola MV, De Silvestro G, Destro R, Pillon M, Calore E, Messina C, Zanesco L. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Hematologica 2002;87:35-41.
3. Platzbecker U, Prange-Krex G, Bornhauser M, Koch R, Soucek S, Aikele P, Haack A, Haag C, Schuler U, Berndt A, Rutt C, Ehninger G, Holig K. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 2001;41:184-9.
4. Donadieu J, Boutard P, Bernatowska E, Tchernia G, Couillaud G, Philippe N, Le Gall E. A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study Group. Biol Blood Marrow Transplant 1997;3:45-9.
5. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, RuggeiroM, Davis M, Koci B, Hammond W, Gillio A. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-met-HuG-CSF) in patients with severe congenital neutropenias. Hum Cell 1994;7:88-94.
6. Kroger N, Zander AR. Dose and Schedule affect of G-CSF for stem cell mobilization in healthy donors. Leuk Lymphoma 2002;43:1391-5.
7. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Muller-Weihrich S, Pluss HJ, Zintl F, Henze G, Riehm H. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90. Blood 1999;94:3294-306.
8. Knudsen LM, Gaarsdal E, Jensen L Nielsen KJ, Nikolaisen K, Johnsen HE. Improved priming of mobilization of and optimal timing for harvest of peripheral blood stem cells. J Hematother 1996;5:399-406.
9. Nakayama T, Kudo H, Sassa S, Mano Y, Sakamoto S. Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats. Life Sciences 2001;69:1521-9.
10. Falzetti F, Aversa F, Mineli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healty donor, Lancet 1999;353:555.
11. Picardi M, De Rosa G, Selleri C, Scarpato N, Soscia E, Martinelli V, Ciancia R, Rotoli B. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilizatiom Haematologica 2003; 88:794-800.
12. Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor, Semin Hematol 2002;39:134-40.
13. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heart SO. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cell. Biol Blood Marrow Transplant 1997;3:45-9.